1 completed, 1 recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Maple Leaf Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY Efavirenz 600mg - Hiv | Not applicable | Recruiting | University of Toronto | 26 | 2025-01-14 | 2026-03-17 |
| PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP) Alcohol-focused brief intervention - Hazardous Alcohol Use | Not applicable | Completed | Centre for Addiction and Mental Health | 122 | 2021-09-28 | 2025-02-10 |
Acquired Immunodeficiency Syndrome (1) · Depression (1) · Substance-Related Disorders (1)
Canada (2)
Colin Kovacs, MD (1) · Mario Ostrowski, MD (1) · Paul A. Shuper, PhD (1)